Life sciences · Journal article
Current Oncology · October 19, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Insomnia and anxiety affect many gynecological cancer patients on chemotherapy, and non-pharmacological options are limited. This randomized trial examined whether adding electroacupuncture (EA) to cognitive behavioral therapy for insomnia (CBT-I) improves both conditions. Seventy-six patients received EA + CBT-I or sham EA + CBT-I for 4 weeks. Outcomes included sleep quality (PSQI), insomnia severity (AIS), anxiety (HAMA), objective sleep parameters, and overall response rate. At Week 4, the EA group showed a greater reduction in PSQI global score (mean difference in change from baseline: −3.11, 95% CI: −4.11 to −2.11, p < 0.001). More patients in the EA group achieved AIS ≤ 6 (71.1% vs. 42.1%, p = 0.010) and HAMA ≤ 14 (92.1% vs. 65.8%, p = 0.005). Deep sleep (p = 0.001), REM sleep (p = 0.045), and sleep score (p = 0.008) also increased more with EA group. The overall response rate was higher with EA (92.1% vs. 71.1%, p = 0.016). No serious adverse events occurred. These findings suggest that adding EA to CBT-I improves sleep and anxiety in this population, with a favorable safety profile.